Dongwon Yoon Assistant Professor

Pharmaceutical Sciences

윤동원 프로필 사진

				
  • Pharmaceutical Science Building A(Appenzeller Hall) #205
  • 02-3277-4685
  • Office hours
    • 수요일 16:00-18:00
  • Research Interests
    • Pharmacoepidemiology, Pharmacovigilance, Immunoepidemiology, Aging
Research Record
  • [학술지논문] Association of Influenza Vaccination During Pregnancy with Health Outcomes in Mothers and Children: A Population-Based Cohort Study CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, v.117 no.5 , 1381-1392
    SCIE
  • [학술지논문] Cardiovascular, cancer, and infection risks of Janus kinase inhibitors in rheumatoid arthritis and ulcerative colitis: A nationwide cohort study JOURNAL OF INTERNAL MEDICINE, 2025, v.297 no.4 , 366-381
    SCIE
  • [학술지논문] Immune responses to infection and autoimmune diseases in the UK biobank Journal of Translational Autoimmunity, 2025, v.11 no.- , 100315-100315
    Scopus
  • [학술지논문] Psychological Adverse Events and Associated Safety Profiles of Doxepin: A Pharmacovigilance Study Using VigiBase JOURNAL OF KOREAN MEDICAL SCIENCE, 2025, v.40 no.40 , 1-12
    SCIE
  • [학술지논문] Risk of new-onset seizures following immunization against COVID-19: a self-controlled case-series study Epidemiology and health, 2025, v.47 no.- , 024-024
    SCIE
  • [학술지논문] Cardiovascular, Neurological, and Immunological Adverse Events and the 23-Valent Pneumococcal Polysaccharide Vaccine JAMA NETWORK OPEN, 2024, v.7 no.1 , 2352597-2352597
    SCIE
  • [학술지논문] Dynamic Patterns and Persistence of Anticoagulation Therapy in Patients with Venous Thromboembolism in South Korea: A Nationwide Cohort Study THROMBOSIS AND HAEMOSTASIS, 2024, v.124 no.02 , 152-162
    SCIE
  • [학술지논문] Evaluation of the Regulatory Required Post-Authorization Safety Study for Propacetamol: Nested Case-Control and Case-Time-Control Studies YONSEI MEDICAL JOURNAL, 2024, v.65 no.2 , 120-128
    SCIE
  • [학술지논문] Investigating the safety profiles of exogenous melatonin and associated adverse events: A pharmacovigilance study using WHO-VigiBase JOURNAL OF PINEAL RESEARCH, 2024, v.76 no.2 , 12949-12949
    SCIE
  • [학술지논문] Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021-2022 EMERGING INFECTIOUS DISEASES, 2024, v.30 no.11 , 2313-2322
    SCIE
  • [학술지논문] Risk of anaphylaxis after COVID-19 vaccination in South Korea: A nationwide self-controlled case series analysis ALLERGY, 2024, v.79 no.3 , 754-757
    SCIE
  • [학술지논문] A Nationwide Survey of mRNA COVID-19 Vaccinee's Experiences on Adverse Events and Its Associated Factors JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, v.38 no.22 , 170-170
    SCIE
  • [학술지논문] Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study CANCER MEDICINE, 2023, v.12 no.21 , 20538-20543
    SCIE
  • [학술지논문] Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism BMC MEDICINE, 2023, v.21 no.1 , 375-375
    SCIE
  • [학술지논문] Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study BMJ-BRITISH MEDICAL JOURNAL, 2021, v.372 no.0 , 4931-4931
    SCIE
Courses
  • 2026-1st

    • Industrial Pharmacy & Administrative Pharmacy Practice

      • Subject No 37153Class No 02
      • 6Year ( 2.5Credit , 160Hour)
      • Major Requisite
    • Pharmaco Epdemiology

      • Subject No 38985Class No 01
      • 5Year ( 1.5Credit , 1.5Hour) Wed 4~4 (POSCO261)
    • Essential Pharmacy Practice Experiences 강의 계획서 상세보기

      • Subject No 39014Class No 01
      • 5Year ( 3Credit , 4.5Hour) Tue 5~10 (PHM-A214)
      • Major Requisite
    • Essential Pharmacy Practice Experiences 강의 계획서 상세보기

      • Subject No 39014Class No 02
      • 5Year ( 3Credit , 4.5Hour) Mon 5~10 (PHM-A214)
      • Major Requisite
    • Essential Pharmacy Practice Experiences 강의 계획서 상세보기

      • Subject No 39014Class No 03
      • 5Year ( 3Credit , 4.5Hour) Wed 5~10 (PHM-A214)
      • Major Requisite
    • Essential Pharmacy Practice Experiences 강의 계획서 상세보기

      • Subject No 39014Class No 04
      • 5Year ( 3Credit , 4.5Hour) Mon 5~10 (PHM-A214)
      • Major Requisite
    • Pharmaceutical Statistics Computer Lab

      • Subject No 39027Class No 01
      • 1Year ( 1.5Credit , 1.5Hour) Wed 6~6 (POSCO159)
      • Major Requisite
    • Pharmaco Epdemiology

      • Subject No 39090Class No 01
      • 5Year ( 1.5Credit , 1.5Hour) Wed 2~2 (POSCO551)
      • Major Requisite
    • Project Analysis Ⅰ

      • Subject No G16659Class No 01
      • Year ( 3Credit , 3Hour) Fri 7~8 (PHM-)
    • Statistical Methods in Applied Research Ⅰ 강의 계획서 상세보기

      • Subject No G16817Class No 01
      • Year ( 3Credit , 3Hour) Mon 8~9 (PHM-A204)
    • Advanced Biotechnology Equipment and Experiments 강의 계획서 상세보기

      • Subject No G18929Class No 01
      • Year ( 3Credit , 3Hour) Tue 6~7 (PHM-)
    • Biostatistics 강의 계획서 상세보기

      • Subject No AP503Class No 01
      • Year ( 3Credit , 3Hour)
    • Biostatistics 강의 계획서 상세보기

      • Subject No AR503Class No 01
      • Year ( 3Credit , 3Hour)
  • 2025-2nd